0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Balloon pulmonary angioplasty (BPA) is an alternative therapy for patients with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary endarterectomy-the standard therapy. Currently, most reported results of BPA are from relatively small cohorts treated at single centers. The present study evaluated the safety and efficacy of BPA for chronic thromboembolic pulmonary hypertension based on a multicenter registry.

          Related collections

          Author and article information

          Journal
          Circ Cardiovasc Qual Outcomes
          Circulation. Cardiovascular quality and outcomes
          Ovid Technologies (Wolters Kluwer Health)
          1941-7705
          1941-7713
          Nov 2017
          : 10
          : 11
          Affiliations
          [1 ] From the Department of Clinical Science, National Hospital Organization Okayama Medical Center, Japan (A.O., H.M.); Division of Cardiology, Department of Medicine, Kyorin University School of Medicine, Tokyo, Japan (T.S.); Department of Radiology (T.F.) and Department of Cardiovascular Surgery (K.M.), National Cerebral and Cardiovascular Center, Suita, Japan; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (K.S.); Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan (Y.F.); Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan (N.E.); Department of Clinical Pharmacy, Kobe Pharmaceutical University, Japan (N.E.); Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan (N.Y.); Division for Health Service Promotion, University of Tokyo, Japan (A.Y.); Department of Cardiovascular Surgery, Cardiovascular Center, Daiyukai General Hospital, Ichinomiya, Japan (M.A.); Department of Cardiovascular Surgery, Tokyo Medical University, Japan (H.O.); Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Japan (N.T.); First Department of Medicine, Hokkaido University Hospital, Sapporo, Japan (I.T.); First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan (M.H.); and Department of Cardiovascular Medicine, Okayama University, Japan (H.I.).
          [2 ] From the Department of Clinical Science, National Hospital Organization Okayama Medical Center, Japan (A.O., H.M.); Division of Cardiology, Department of Medicine, Kyorin University School of Medicine, Tokyo, Japan (T.S.); Department of Radiology (T.F.) and Department of Cardiovascular Surgery (K.M.), National Cerebral and Cardiovascular Center, Suita, Japan; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (K.S.); Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan (Y.F.); Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan (N.E.); Department of Clinical Pharmacy, Kobe Pharmaceutical University, Japan (N.E.); Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan (N.Y.); Division for Health Service Promotion, University of Tokyo, Japan (A.Y.); Department of Cardiovascular Surgery, Cardiovascular Center, Daiyukai General Hospital, Ichinomiya, Japan (M.A.); Department of Cardiovascular Surgery, Tokyo Medical University, Japan (H.O.); Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Japan (N.T.); First Department of Medicine, Hokkaido University Hospital, Sapporo, Japan (I.T.); First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan (M.H.); and Department of Cardiovascular Medicine, Okayama University, Japan (H.I.). matsubara.hiromi@gmail.com.
          Article
          CIRCOUTCOMES.117.004029
          10.1161/CIRCOUTCOMES.117.004029
          29101270
          d5060d32-7cfe-4862-8be3-01a9c516dd86

          Comments

          Comment on this article